These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
358 related articles for article (PubMed ID: 30246434)
1. Childhood supratentorial ependymomas with YAP1-MAMLD1 fusion: an entity with characteristic clinical, radiological, cytogenetic and histopathological features. Andreiuolo F; Varlet P; Tauziède-Espariat A; Jünger ST; Dörner E; Dreschmann V; Kuchelmeister K; Waha A; Haberler C; Slavc I; Corbacioglu S; Riemenschneider MJ; Leipold A; Rüdiger T; Körholz D; Acker T; Russo A; Faber J; Sommer C; Armbrust S; Rose M; Erdlenbruch B; Hans VH; Bernbeck B; Schneider D; Lorenzen J; Ebinger M; Handgretinger R; Neumann M; van Buiren M; Prinz M; Roganovic J; Jakovcevic A; Park SH; Grill J; Puget S; Messing-Jünger M; Reinhard H; Bergmann M; Hattingen E; Pietsch T Brain Pathol; 2019 Mar; 29(2):205-216. PubMed ID: 30246434 [TBL] [Abstract][Full Text] [Related]
2. YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis. Pajtler KW; Wei Y; Okonechnikov K; Silva PBG; Vouri M; Zhang L; Brabetz S; Sieber L; Gulley M; Mauermann M; Wedig T; Mack N; Imamura Kawasawa Y; Sharma T; Zuckermann M; Andreiuolo F; Holland E; Maass K; Körkel-Qu H; Liu HK; Sahm F; Capper D; Bunt J; Richards LJ; Jones DTW; Korshunov A; Chavez L; Lichter P; Hoshino M; Pfister SM; Kool M; Li W; Kawauchi D Nat Commun; 2019 Sep; 10(1):3914. PubMed ID: 31477715 [TBL] [Abstract][Full Text] [Related]
3. Supratentorial ependymoma in childhood: more than just RELA or YAP. Zschernack V; Jünger ST; Mynarek M; Rutkowski S; Garre ML; Ebinger M; Neu M; Faber J; Erdlenbruch B; Claviez A; Bielack S; Brozou T; Frühwald MC; Dörner E; Dreschmann V; Stock A; Solymosi L; Hench J; Frank S; Vokuhl C; Waha A; Andreiuolo F; Pietsch T Acta Neuropathol; 2021 Mar; 141(3):455-466. PubMed ID: 33481105 [TBL] [Abstract][Full Text] [Related]
4. C11orf95-RELA fusions and upregulated NF-KB signalling characterise a subset of aggressive supratentorial ependymomas that express L1CAM and nestin. Malgulwar PB; Nambirajan A; Pathak P; Faruq M; Rajeshwari M; Singh M; Suri V; Sarkar C; Sharma MC J Neurooncol; 2018 May; 138(1):29-39. PubMed ID: 29354850 [TBL] [Abstract][Full Text] [Related]
5. Ependymomas in infancy: underlying genetic alterations, histological features, and clinical outcome. Jünger ST; Andreiuolo F; Mynarek M; Dörner E; Zur Mühlen A; Rutkowski S; von Bueren AO; Pietsch T Childs Nerv Syst; 2020 Nov; 36(11):2693-2700. PubMed ID: 32474813 [TBL] [Abstract][Full Text] [Related]
7. Diagnostics of pediatric supratentorial RELA ependymomas: integration of information from histopathology, genetics, DNA methylation and imaging. Pagès M; Pajtler KW; Puget S; Castel D; Boddaert N; Tauziède-Espariat A; Picot S; Debily MA; Kool M; Capper D; Sainte-Rose C; Chrétien F; Pfister SM; Pietsch T; Grill J; Varlet P; Andreiuolo F Brain Pathol; 2019 May; 29(3):325-335. PubMed ID: 30325077 [TBL] [Abstract][Full Text] [Related]
8. Phenotypic characterization with somatic genome editing and gene transfer reveals the diverse oncogenicity of ependymoma fusion genes. Takadera M; Satomi K; Szulzewsky F; Cimino PJ; Holland EC; Yamamoto T; Ichimura K; Ozawa T Acta Neuropathol Commun; 2020 Nov; 8(1):203. PubMed ID: 33228790 [TBL] [Abstract][Full Text] [Related]
9. Supratentorial ependymoma with YAP1:FAM118B fusion: A case report. Wang J; Wang L; Fu L; Li QC; Qiu XS; Wang EH; Yu JH Neuropathology; 2021 Apr; 41(2):133-138. PubMed ID: 33480048 [TBL] [Abstract][Full Text] [Related]
10. Transcriptional profiling of paediatric ependymomas identifies prognostically significant groups. Łastowska M; Matyja E; Sobocińska A; Wojtaś B; Niemira M; Szałkowska A; Krętowski A; Karkucińska-Więckowska A; Kaleta M; Ejmont M; Tarasińska M; Perek-Polnik M; Dembowska-Bagińska B; Pronicki M; Grajkowska W; Trubicka J J Pathol Clin Res; 2021 Nov; 7(6):565-576. PubMed ID: 34314101 [TBL] [Abstract][Full Text] [Related]
12. CNS tumors with PLAGL1-fusion: beyond ZFTA and YAP1 in the genetic spectrum of supratentorial ependymomas. Tauziède-Espariat A; Nicaise Y; Sievers P; Sahm F; von Deimling A; Guillemot D; Pierron G; Duchesne M; Edjlali M; Dangouloff-Ros V; Boddaert N; Roux A; Dezamis E; Hasty L; Lhermitte B; Hirsch E; Hirsch MPV; Ardellier FD; Karnoub MA; Csanyi M; Maurage CA; Mokhtari K; Bielle F; Rigau V; Roujeau T; Abad M; Klein S; Bernier M; Horodyckid C; Adam C; Brandal P; Niehusmann P; Vannod-Michel Q; Provost C; de Champfleur NM; Nichelli L; Métais A; Mariet C; Chrétien F; Blauwblomme T; Beccaria K; Pallud J; Puget S; Uro-Coste E; Varlet P; Acta Neuropathol Commun; 2024 Apr; 12(1):55. PubMed ID: 38581034 [TBL] [Abstract][Full Text] [Related]
13. YAP1 fusion-positive supratentorial ependymoma in an infant: clinical, imaging and therapeutic considerations for a rare entity. Henriques V; Soares JG; Costa JA BMJ Case Rep; 2024 Jul; 17(7):. PubMed ID: 39038871 [No Abstract] [Full Text] [Related]
14. Non-supratentorial YAP1- fused ependymomas: report of two cases. Wang L; Cheng L; Fu Y; Dong H; Xiong Y; Lu D; Piao Y; Teng L Acta Neuropathol Commun; 2024 Oct; 12(1):158. PubMed ID: 39369248 [No Abstract] [Full Text] [Related]